EVEREST ORGANICS
Back to Cashflow Statement
|
EVEREST ORGANICS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-8.45 Cr | ₹16 Cr | ₹-3.10 Cr | ₹-2.64 Cr | ₹2.07 Cr |
What is the latest Cash Flow from Financing Activities ratio of EVEREST ORGANICS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-8.45 Cr |
| Mar2025 | ₹16 Cr |
| Mar2024 | ₹-3.10 Cr |
| Mar2023 | ₹-2.64 Cr |
| Mar2022 | ₹2.07 Cr |
How is Cash Flow from Financing Activities of EVEREST ORGANICS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-8.45 Cr | Negative | |
| Mar2025 | ₹16 Cr | Positive | |
| Mar2024 | ₹-3.10 Cr | Negative | |
| Mar2023 | ₹-2.64 Cr | Negative | |
| Mar2022 | ₹2.07 Cr | - | |
Compare Cash Flow from Financing Activities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹252.0 Cr | 0.3% | 11.6% | -41.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,017.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 0.3% |
11.6% |
-41.1% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses